Nothing Special   »   [go: up one dir, main page]

Skip to main content

Arthritis Research & Therapy: Celebrating 25 Years

2024 marks 25 years since Arthritis Research & Therapy published its 1st article. Click the banner to read more about the history of Arthritis Research & Therapy, and learn of some milestone achievements from throughout the journals history.

From joint injury to joint replacement – Untangling the pathomechanisms of posttraumatic osteoarthritis


Edited by:

Dr. Jana Riegger-Koch, University of Ulm, Germany
Dr. Zsuzsa Jenei-Lanzl, PD, Goethe University Frankfurt, University Hospital, Germany

Submission Status: Open until 28 February 2025

CAR T cells in autoimmunity

Edited by:

Professor Adam P. Croft, University of Birmingham, Queen Elizabeth Hospital, UK                                            
Professor Georg Schett, Friedrich Alexander Universität Erlangen-Nürnberg and Universitätsklinikum Erlangen, Germany


Submission Status: Open until 30 November 2024

The Human Cell Atlas applied to musculoskeletal disease (MSK)

Editors:
Christopher Buckley: University of Oxford, UK
Sarah Snelling: University of Oxford, UK

Submission Status: Open until 30 September 2024

Digital Rheumatology

Digital Rheumatology

Arthritis Research & Therapy has launched a thematic series dedicated to the topic Digital Rheumatology.

Articles

Editors-in-Chief

Professor Christopher Buckley, University of Birmingham and University of Oxford, UK
Professor Harris Perlman, Northwestern University, USA

Trending articles

Click here to view which articles have been shared the most in the last month.

First Author Profiles

Meet this month's featured authors!

Aims and scope

Established in 1999, Arthritis Research and Therapy is an international, open access, peer-reviewed journal, publishing original articles in the area of musculoskeletal research and therapy as well as, reviews, commentaries and reports.
A major focus of the journal is on the immunologic processes leading to inflammation, damage and repair as they relate to autoimmune rheumatic and musculoskeletal conditions, and which inform the translation of this knowledge into advances in clinical care.
Original basic, translational and clinical research is considered for publication along with results of early and late phase therapeutic trials, especially as they pertain to the underpinning science that informs clinical observations in interventional studies.

Featured Review: The importance of ultrasound in identifying and differentiating patients with early inflammatory arthritis

New Content ItemKaeley et al. provide an in-depth review of how ultrasound—a portable, convenient, noninvasive, and cost-effective imaging technique—can be used in the differential diagnosis of early inflammatory arthritis phenotypes and also assess any important limitations of the technique. The authors also propose an algorithm that may enable working through a differential diagnosis both clinically and by prioritizing anatomical targets.

Annual Journal Metrics

  • Citation Impact 2023
    Journal Impact Factor: 4.4
    5-year Journal Impact Factor: 4.9
    Source Normalized Impact per Paper (SNIP): 1.294
    SCImago Journal Rank (SJR): 1.518

    Speed 2023
    Submission to first editorial decision (median days): 9
    Submission to acceptance (median days): 111

    Usage 2023
    Downloads: 3,331,819
    Altmetric mentions: 1,885